Volume 20, Issue 7 pp. 1000-1003
Case Report

Challenges managing end-stage renal disease and kidney transplantation in a child with MTFMT mutation and moyamoya disease

Aris Oates

Corresponding Author

Aris Oates

Division of Nephrology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA

Aris Oates, Division of Nephrology, Department of Pediatrics, University of California, San Francisco, 550 16th St, 5th Floor Mailstop 3214, San Francisco, CA 94143, USA

Tel.: 415-476-2423

Fax: 415-476-9976

E-mail: [email protected]

Search for more papers by this author
Jessica Brennan

Jessica Brennan

Division of Transplant, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

Search for more papers by this author
Anne Slavotinek

Anne Slavotinek

Division of Genetics, University of California, San Francisco, San Francisco, CA, USA

Search for more papers by this author
Adnan Alsadah

Adnan Alsadah

Division of Genetics, University of California, San Francisco, San Francisco, CA, USA

Search for more papers by this author
Daniel Chow

Daniel Chow

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA

Search for more papers by this author
Marsha M. Lee

Marsha M. Lee

Division of Nephrology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA

Search for more papers by this author
First published: 08 July 2016
Citations: 6

Abstract

Moyamoya disease is a chronic cerebrovascular disorder with progressive stenosis. We describe a four-yr-old female with features of moyamoya disease referred to our center for kidney transplant evaluation with ESRD secondary to presumed renal dysplasia along with concern for cerebral vascular anomalies. With her constellation of organ involvement, a genetic workup revealed a homozygous, frameshift mutation in the mitochondrial methionyl-tRNA formyltransferase gene. Given her vascular anomalies and evidence of prior infarcts seen on cerebral imaging, it was felt that her risk of future stroke events was high and that hypotension or intravascular volume depletion would further exacerbate this risk. In hopes of improving her tenuous cerebral perfusion, she underwent a bilateral temporal craniotomy for superficial temporal artery to middle cerebral artery bypass. We highlight the challenges faced in a child with ESRD and kidney transplantation when cerebral vasculature is compromised. A multidisciplinary approach is critical in determining the need for a revascularization procedure prior to transplant and to help reduce the risk of ischemic or hemorrhagic events in this patient population.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.